We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Ophthalmology

Ophthalmology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Corneal Nerve Alterations and Sensory Deficits in Unilateral Noninfectious Anterior Uveitis: A Cross-Sectional Study
newsanterior uveitiscorneal nerve plexus

Corneal Nerve Alterations and Sensory Deficits in Unilateral Noninfectious Anterior Uveitis: A Cross-Sectional Study

By MedXY|Jul 5, 2026

In unilateral noninfectious anterior uveitis, affected eyes show reduced corneal sensitivity and nerve abnormalities; importantly, the contralateral eyes also exhibit subtle nerve changes, suggesting bilateral corneal involvement.

Enhancing Glaucoma Diagnosis in Myopia: Validating OCT-Based Prespecified Rules for Optic Neuropathy Detection
newsglaucomaMyopia

Enhancing Glaucoma Diagnosis in Myopia: Validating OCT-Based Prespecified Rules for Optic Neuropathy Detection

By MedXY|Jul 7, 2026

This multicenter study validates prespecified OCT diagnostic rules demonstrating high accuracy in detecting glaucomatous optic neuropathy in nonpathologic myopic eyes, offering improved clinical decision support across diverse populations.

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries
newsDrug UtilizationFee-for-Service

Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries

By MedXY|Jul 5, 2026

Medicare Advantage beneficiaries receive fewer higher-cost anti-VEGF injections compared to Fee-for-Service patients, highlighting potential access disparities to newer ophthalmic therapies.

Breakthrough Optogenetic Therapy UGX-201 Shows Promise for Advanced Retinitis Pigmentosa
newsclinical trialoptogenetic therapy

Breakthrough Optogenetic Therapy UGX-201 Shows Promise for Advanced Retinitis Pigmentosa

By MedXY|Jul 2, 2026

An exploratory trial of UGX-201, a novel optogenetic therapy, demonstrated safety and meaningful visual improvements in patients with advanced nonsyndromic retinitis pigmentosa, including restoration of light perception in those previously

Avacincaptad Pegol Demonstrates Efficacy in Slowing Photoreceptor Loss in Geographic Atrophy via Ellipsoid Zone Preservation
newsage-related macular degenerationAvacincaptad pegol

Avacincaptad Pegol Demonstrates Efficacy in Slowing Photoreceptor Loss in Geographic Atrophy via Ellipsoid Zone Preservation

By MedXY|Jul 2, 2026

Avacincaptad pegol significantly reduces progression of ellipsoid zone degradation and geographic atrophy lesion growth, highlighting its potential to preserve photoreceptor integrity in AMD patients.

Stimulating Thyrotropin Receptor Antibodies Amplify Fibroblast Expression of TSH and IGF-1 Receptors: Insights into Thyroid Eye Disease Pathogenesis
Diabetes & Endocrinologyautoantibodiesfibroblasts

Stimulating Thyrotropin Receptor Antibodies Amplify Fibroblast Expression of TSH and IGF-1 Receptors: Insights into Thyroid Eye Disease Pathogenesis

By MedXY|Jul 1, 2026

Stimulating TSH receptor antibodies enhance expression of TSHR and IGF-1R in fibroblasts via receptor recycling, elucidating mechanisms underlying thyroid eye disease and identifying potential therapeutic targets.

Posterior Segment Risk Factors Influencing Penetrating Keratoplasty Graft Survival
newsgraft failurepenetrating keratoplasty

Posterior Segment Risk Factors Influencing Penetrating Keratoplasty Graft Survival

By MedXY|Jun 29, 2026

This study identifies intraoperative vitreous hemorrhage and silicone oil tamponade as significant posterior segment risk factors for graft failure post-penetrating keratoplasty, highlighting critical considerations in managing complex corn

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial
Infectious Diseasesclinical trialInfectious Keratitis

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

By MedXY|Jun 29, 2026

A 12-month follow-up of the REAGIR trial found no significant benefit of adjunctive rose bengal photodynamic therapy with green light over sham treatment in improving visual acuity, scar size, or complication rates in infectious keratitis.

Enhancing Glaucoma Research Accuracy: Contrasting Diagnostic and Treatment-Based Definitions in UK Biobank
newsglaucomaÁp lực nội nhãn

Enhancing Glaucoma Research Accuracy: Contrasting Diagnostic and Treatment-Based Definitions in UK Biobank

By MedXY|Jun 29, 2026

This study compares diagnostic-only versus combined diagnostic and treatment-based definitions of glaucoma in UK Biobank participants, revealing stronger associations of risk factors and severity biomarkers with definitions including treatm

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion
newsage-related macular degenerationdopamine

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion

By MedXY|Jun 25, 2026

This study evaluates the association of dopamine-enhancing drugs, especially levodopa, with lowered 3-year risk of progression from non-neovascular to neovascular AMD, offering promising insight into dopaminergic pathways in AMD management.

Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® Registry
newsCataract surgeryĐánh giá rủi ro

Assessing the Impact of Cataract Surgery on Progression from Dry to Neovascular Age-Related Macular Degeneration: Insights from the IRIS® Registry

By MedXY|Jun 25, 2026

A large retrospective study from the IRIS® Registry reveals a modest, time-dependent increase in neovascular AMD risk following cataract surgery in patients with dry AMD, with implications for perioperative evaluation and patient counseling

Ripasudil After DSO in Fuchs Endothelial Corneal Dystrophy: A Randomized Trial Signals a New Path to Corneal Recovery
newscorneal endothelial recoveryDescemet stripping only

Ripasudil After DSO in Fuchs Endothelial Corneal Dystrophy: A Randomized Trial Signals a New Path to Corneal Recovery

By MedXY|Jun 19, 2026

A phase 2 randomized trial found that topical ripasudil after DSO improved endothelial cell density, sped edema clearance, and reduced rescue therapy in FECD, especially with QID dosing.

Retinal Microvascular Clues to Alzheimer Disease: What Swept-Source OCT Angiography Reveals About Neurovascular Dysfunction
NeurologyAlzheimer diseaseneurovascular dysfunction

Retinal Microvascular Clues to Alzheimer Disease: What Swept-Source OCT Angiography Reveals About Neurovascular Dysfunction

By MedXY|Jun 19, 2026

SS-OCTA identified retinal and choriocapillaris microvascular changes associated with cognitive status in Alzheimer disease, including thinner GCC in dementia and a biphasic CCFD pattern, suggesting a promising noninvasive biomarker platfor

Calm in the Clinic? Digital Mindfulness Shows Promise for Anxiety and Depression in Non-infectious Uveitis
newsanxietydepression

Calm in the Clinic? Digital Mindfulness Shows Promise for Anxiety and Depression in Non-infectious Uveitis

By MedXY|Jun 19, 2026

A randomized trial found that an 8-week digital mindfulness app improved anxiety, depression, and stress in adults with non-infectious uveitis, but did not significantly change vision-related quality of life.

Optimized AAV5-RPGR Gene Therapy Rescues Photoreceptor Integrity and Function in X-Linked Retinitis Pigmentosa Mouse Model
newsAAV5gene therapy

Optimized AAV5-RPGR Gene Therapy Rescues Photoreceptor Integrity and Function in X-Linked Retinitis Pigmentosa Mouse Model

By MedXY|Jun 13, 2026

An optimized AAV5 vector delivering a stabilized human RPGR ORF15 gene significantly restores photoreceptor structure and function in RPGR-deficient mice, demonstrating a promising gene therapy for X-linked retinitis pigmentosa.

Familial Patterns of Strabismus and Subnormal Stereopsis in Parents of Affected Children: Implications for Genetic Research
newsFamilial InheritanceOphthalmic Genetics

Familial Patterns of Strabismus and Subnormal Stereopsis in Parents of Affected Children: Implications for Genetic Research

By MedXY|Jun 11, 2026

A large prospective study reveals high prevalence of strabismus and decreased stereopsis in parents of children with strabismus, underscoring familial inheritance and subclinical phenotypes useful for genetic studies.

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
Diabetes & EndocrinologyGLP-1 receptor agonistneovascular age-related macular degeneration

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study

By MedXY|Jun 10, 2026

In a large OHDSI network study of adults with type 2 diabetes, semaglutide was not associated with a higher or lower risk of neovascular age-related macular degeneration.

Subclinical Peripheral Vascular Leakage in Demyelinating Disease-Associated Uveitis: What Ultra-Widefield Angiography Adds Beyond Clinical Quiescence
Clinical Updatesfluorescein angiographymultiple sclerosis

Subclinical Peripheral Vascular Leakage in Demyelinating Disease-Associated Uveitis: What Ultra-Widefield Angiography Adds Beyond Clinical Quiescence

By MedXY|Jun 9, 2026

A new cohort study suggests ultra-widefield fluorescein angiography frequently detects persistent peripheral leakage in clinically inactive demyelinating disease-associated uveitis, highlighting a potential gap between examination-based rem

Retinal Nerve Fiber Layer Thickness at 36 Weeks May Help Predict 2-Year Neurodevelopment in Very Preterm Infants
newsneurodevelopmentpreterm infant

Retinal Nerve Fiber Layer Thickness at 36 Weeks May Help Predict 2-Year Neurodevelopment in Very Preterm Infants

By MedXY|Jun 8, 2026

In very preterm infants, thicker retinal nerve fiber layer on OCT at 36 weeks’ postmenstrual age was associated with better motor and cognitive outcomes at 2 years, supporting retinal imaging as a potential early neurodevelopmental biomarke

Poor Glycemic Control and Higher Blood Pressure Track With Early Diabetic Retinal Disease in Youth With Type 1 Diabetes
Diabetes & EndocrinologyHbA1cretinal neurodegeneration

Poor Glycemic Control and Higher Blood Pressure Track With Early Diabetic Retinal Disease in Youth With Type 1 Diabetes

By MedXY|Jun 8, 2026

A large retrospective study links higher HbA1c and elevated blood pressure to diabetic retinopathy in youth with type 1 diabetes, while worse glycemia also correlates with thinner inner retinal layers suggestive of early neurodegeneration.

Prev
6 / 12
1…45678…12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles